The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in pediatric Type 2 diabetes patients improves short term time in range glucose control and 3-6 month glycemic control.
The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for 10 days has an impact on short and long term glycemic control and behavior in youth onset Type 2 diabetes.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
41
Eligible patients will have a Dexcom G6 Continuous Glucose Monitor placed for 10 days.
Johns Hopkins Pediatric Diabetes Center
Baltimore, Maryland, United States
Percentage of Time in Range Glucose Control
The percentage of total time that the patient uses the continuous glucose monitor (CGM) where the blood glucose falls between 70 and 180 mg/dL
Time frame: 5 days, 10 days
Hemoglobin A1c
HbA1c at baseline and 3-6 month follow-up.
Time frame: Baseline, 3 - 6 months
More Frequent Insulin Administration
Response to "Did you take your insulin more often than before?"
Time frame: 10 days from CGM placement
More Frequent Glycemic Control Monitoring
Response to "Do you look at or check your blood sugar more often than before?"
Time frame: 10 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.